CLAIMS DATA ANALYSIS OF PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) IN GERMANY

被引：0
|
作者：
Bartsch, R. [1 ]
Zimmermann, L. [2 ]
Reis, L. [1 ]
Hecker, D. [3 ]
Lebioda, A. [3 ]
机构：
[1] Amgen GmbH, Munich, Germany
[2] Gesundheitsforen Leipzig GmbH, Leipzig, Germany
[3] Amgen GmbH, Munich, Germany
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN177
引用
收藏
页码：S453 / S453
页数：1
相关论文
共 50 条
  • [31] Phase II trial of figitumumab in patients with refractory, metastatic colorectal cancer (mCRC)
    Becerra, C.
    Salazar, R.
    Garcia-Carbonero, R.
    Thomas, A. L.
    Vazquez-Mazon, F.
    Cassidy, J.
    Maughan, T.
    Gallen, M.
    Iveson, T.
    Hixon, M.
    Gualberto, A.
    Yin, D.
    Bergsland, E. K.
    Li, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] Skin toxicity in elderly patients with metastatic colorectal cancer (mCRC) treated with Cetuximab
    Jehn, C.
    Stenzel, L.
    Boening, L.
    Kroening, H.
    Possinger, K.
    Lueftner, D.
    ONKOLOGIE, 2010, 33 : 175 - 176
  • [33] Biweekly gemcitabine and capecitabine in heavily pretreated patients with metastatic colorectal cancer (mCRC)
    Solis Hernandez, Maria Del Pilar
    Jimenez, Paula
    Faez Garcia, Laura
    Alvarez Fernandez, Carlos
    Perez Arnillas, Quionia
    Rodriguez Rubi, David Jose
    Lucrecia Ruiz, Ana
    Sanchez Lorenzo, Luisa
    Li Torres, Walter Antonio
    Uriol, Esther
    Dolores, Maria
    Prieto, Menendez
    Maria Vieitez de Prado, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] GOLFIG chemo-immunotherapy in metastatic colorectal cancer (mCRC) patients: A fifteen year retrospective analysis
    Correale, P.
    Staropoli, N.
    Pastina, P.
    Giannicola, R.
    Botta, C.
    Francini, E.
    Ridolfi, L.
    Mini, E.
    Ciliberto, D.
    Agostino, R. M.
    Strangio, A.
    Azzarello, D.
    Nardone, V.
    Falzea, A.
    Tassone, P.
    Giordano, A.
    Pirtoli, L.
    Francini, G.
    Tagliaferri, P. S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [35] Circulating microRNAs in metastatic colorectal cancer (mCRC) patients (pts) treated with regorafenib
    Antoniotti, C.
    Loupakis, F.
    Schirripa, M.
    Cremolini, C.
    Poliseno, L.
    Salvatore, L.
    Tuccoli, A.
    D'Aurizio, R.
    Marmorino, F.
    Borelli, B.
    Rossini, D.
    Saettini, A.
    Gini, S.
    Moretto, R.
    Rizzo, I.
    Dell'Aquila, E.
    Pellegrini, M.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2015, 26 : 37 - 38
  • [36] Cetuximab (Cet) clearance and survival in patients (pts) with metastatic colorectal cancer (mCRC)
    Jiang, Di Maria
    Sim, Hao-Wen
    Siu, Lillian L.
    Shapiro, Jeremy David
    Liu, Geoffrey
    Price, Timothy Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [37] Quantitative urinary KRAS for treatment decisions in patients with metastatic colorectal cancer (mCRC)
    Melnikova, Vladislava
    Vibat, Cecile Rose T.
    Ning, Van
    Agafitei, Raluca Dana
    Hanna, Diana L.
    Hancock, Saege
    Erlander, Mark G.
    Lenz, Heinz-Josef
    Barzi, Afsaneh
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer (mCRC).
    Paramore, L. C.
    Thomas, S.
    Knopf, K. B.
    Cragin, L.
    Fraeman, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 321S - 321S
  • [39] Cetuximab (Cet) clearance and survival in patients (pts) with metastatic colorectal cancer (mCRC).
    Jiang, Di Maria
    Sim, Hao-Wen
    Siu, Lillian L.
    Shapiro, Jeremy David
    Liu, Geoffrey
    Price, Timothy Jay
    Jonker, Derek J.
    Karapetis, Christos Stelios
    Strickland, Andrew
    Zhang, Wenjiang
    Jeffery, Mark
    Tu, Dongsheng
    Ng, Siobhan
    Sabesan, Sabe S.
    Shannon, Jenny
    Townsend, Amanda Rose
    Morgen, Eric
    Xu, Wei
    O'Callaghan, Christopher J.
    Chen, Eric Xueyu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Chemotherapy-induced thrombocytopenia (CIT) in metastatic colorectal cancer (mCRC) patients
    Cetin, K.
    Toler, A.
    Eisen, M.
    Soff, G. A.
    ANNALS OF ONCOLOGY, 2017, 28
12345